These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 24440439)

  • 61. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
    Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
    Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.
    Yamaguchi T
    Stroke; 2000 Apr; 31(4):817-21. PubMed ID: 10753981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
    Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
    Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
    J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
    Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
    Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
    [TBL] [Abstract][Full Text] [Related]  

  • 67. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can early effective anticoagulation prevent new lesions on magnetic resonance imaging in acute cardioembolic stroke?
    Nomura E; Ohshita T; Imamura E; Wakabayashi S; Kajikawa H; Matsumoto M
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2099-2104. PubMed ID: 25106835
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Meta-analysis of efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation.
    Jia B; Lynn HS; Rong F; Zhang W
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):368-74. PubMed ID: 24869601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment.
    Pengo V; Barbero F; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
    Thromb Haemost; 2003 Apr; 89(4):760-4. PubMed ID: 12669133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.
    Jacobs V; Woller SC; Stevens S; May HT; Bair TL; Anderson JL; Crandall BG; Day JD; Johanning K; Long Y; Mallender C; Olson JL; Osborn JS; Weiss JP; Bunch TJ
    Heart Rhythm; 2014 Dec; 11(12):2206-13. PubMed ID: 25111326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.
    European Atrial Fibrillation Trial Study Group
    N Engl J Med; 1995 Jul; 333(1):5-10. PubMed ID: 7776995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
    Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
    Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention.
    Paciaroni M; Agnelli G; Ageno W; Caso V; Corea F; Lanari A; Alberti A; Previdi P; Fedele M; Manina G; Vedovati C; Venti M; Billeci AM; Batta M; Galli L; Silvestrelli G
    Atherosclerosis; 2010 Oct; 212(2):564-6. PubMed ID: 20599199
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
    Fang MC; Chang Y; Hylek EM; Rosand J; Greenberg SM; Go AS; Singer DE
    Ann Intern Med; 2004 Nov; 141(10):745-52. PubMed ID: 15545674
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
    Lane DA; Kamphuisen PW; Minini P; Büller HR; Lip GYH
    Chest; 2011 Jul; 140(1):146-155. PubMed ID: 21415134
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.
    Gallagher AM; Setakis E; Plumb JM; Clemens A; van Staa TP
    Thromb Haemost; 2011 Nov; 106(5):968-77. PubMed ID: 21901239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.